Sanofi Shares Fall After Multiple Sclerosis Drug Gets Hit by Double Setback [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
a key goal and U.S. regulators signaling a decision on the drug would be delayed again. Shares in the French drugmaker were down about 5% in European morning trading Monday, taking their year-to-date loss to nearly 16%. Transportation Stocks Are Hitting Their Stride. That's a Good Sign for Investors. Roomba Maker Declares Bankruptcy, but Tries to Ease ‘Bricking' Fears SpaceX Starts a Wall Street Bake-Off to Hire Banks for Possible IPO Our 3-D Model Guides You Through Epstein's Secretive Island, Little St. James Tonka Trucks Gambled on Keeping Production in China and Survived—Barely Sanofi said its tolebrutinib drug candidate didn't meet the primary goal in a late-stage clinical trial for multiple sclerosis. It separately said talks with the U.S. Food and Drug Administration had indicated a regulatory review for tolebrutinib in a different form of the disease would take longer than previously expected. The updates deal a blow to one of the most advanced drugs in Sanofi'
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Sanofi in deal worth up to $1.7B with Dren Bio for autoimmune disease treatments [Seeking Alpha]Seeking Alpha
- Scribe Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- 5 Things to Know Before the Stock Market Opens [Yahoo! Finance]Yahoo! Finance
- Dren Bio Expands Strategic Collaboration with Sanofi to Develop Next-Generation B-Cell Depletion Therapy [Yahoo! Finance]Yahoo! Finance
- Dren Bio Expands Strategic Collaboration with Sanofi to Develop Next-Generation B-Cell Depletion TherapyBusiness Wire
SNY
Sec Filings
- 12/15/25 - Form 6-K
- 12/12/25 - Form 6-K
- 12/3/25 - Form 6-K
- SNY's page on the SEC website